Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001437749-25-028705

General Counsel sold 1,520 shares at $19.11 ($29,047)

  • General Counsel acquired 3,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Smith Jason Drew · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-07 Exercise or conversion : show line 1 in the form +3,333 44,825 D
2025-09-08 Sale : show line 2 in the form −1,520 $19.11 $29,047 43,305 D
Open-market sales · 1,520 sh · avg $19.11 · $29,047

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-07 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,333 3,334 D
Loading xslF345X05/rdgdoc.xml…